Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE ...

The deadline for required immunizations for Muscogee County School District is technically July 31, but schools allow a ...

President Trump pledged to assist Dilbert cartoonist Scott Adams in securing treatment for his advanced prostate cancer. Adams had publicly appealed t ...

GSK is set to acquire the exclusive rights for Syndivia’s preclinical antibody-drug conjugate (ADC), which is currently in ...

(“Sintana ”) and Challenger Energy Group plc (“Challenger ”) earlier today, we have reached another milestone associated with our proposed all-share acquisition of Challenger. A Scheme Document in ...

Daneng Li, MD, of City of Hope talks about research presented at the North American Neuroendocrine Tumor Society (NANETS) 2025 meeting.

Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with ...

In a recent government press conference held to launch the Visit Malaysia 2026 campaign, a question about national language ...

LFD-200 achieves sustained GC exposures in immune cells of non-human primates and suppresses proinflammatory cytokine expression without evidence of toxicity -- Phase 1 study of LFD-200 in Rheumatoid ...

Samsung Bioepis and Phrontline will co-develop two investigational antibody-drug conjugate (ADC) assets directed against ...